
V. RIPETTI ET AL.
424
infiltration substantially in the long term. In general, the
crosslinked materials also demonstrated increased scores
at 12 months for cell types, ECM deposition, scaffold
degradation, fibrous encapsulation, and neovasculariza-
tion compared with their scores at 1 month. Although
many differences were identified among the biologic
meshes examined in this study, it is difficult to say
whether any of these biologic meshes are more biocom-
patible than the others for ventral hernia repair because
there are such wide variations in both the clinical sce-
narios analyzed and the biological responses of individ-
ual patients [26]. Also, a retrospective comparative study,
in 2012, on synthetic and biological meshes in compo-
nent separation for abdominal wall hernia repairs,
showed a recurrence rate in PermacolTM repair in con-
taminated fields of 7.7%, compared with Alloderm
(19%), synthetic mesh (25.6%), and component separa-
tion (12%). This review suggests that the crosslinked
mesh, PermacolTM, has the lowest failure rate and the
longest time to failure, particularly in contaminated or
infected fields [27]. In our cases there was a late clinical
presentation of mesh migration, where pus output was
the only sign of infection, with none of the abdominal
pain or bowel occlusion reported by Di Muria [2]. In the
first case the periumbilical pus output was caused by
enterocutaneous fistula formation, and in the second it
was due to partial external mesh migration. In both cases
we decided, in accordance with the literature concerning
mesh infection, to remove the infected mesh and perfo rm
an abdominal wall repair using bioprosthesis mesh to
ensure lower risk of recurrence and infection. Our ex-
perience confirms this biodegradable matrix as a safe and
useful tool; therefore it should be the device of choice
when there is high risk of infection and migration, or of
major complications such as intestinal perforation. In
conclusion, our cases are the first to be reported in which
mesh migration is associated with infection after umbili-
cal hernia repair, and they demonstrate the advantages of
biologic implants in abdominal wall reconstruction. Bio-
logical devices such as PermacolTM should be considered
in cases of contaminated wounds, immunesuppressed
patients, and previously placed, infected mesh, even if
high cost limits th eir routine use.
REFERENCES
[1] M. Basoglu, M. I. Yildirgan, I. Yilmaz, et al., “Late Com-
plications of Incisional Hernias Following Prosthetic
Mesh Repair,” Acta Chirurgica Belgica, Vol. 104, No. 4,
2004, pp. 425-428.
[2] A. Di Muria, V. Formisano, F. Di Carlo, et al., “Small
Bowel Obstruction by Mesh Migration after Umbilical
Hernia Repair,” Annali Italiani di Chirurgia, Vol. 78, No.
1, 2007, pp. 59-60.
[3] N. Dabbas, K. Adams, K. Pearson, et al., “Frequency of
Abdominal Wall Hernias: Is Classical Teaching Out of
Date?” JRSM Short Reports, Vol. 2, No. 1, 2007, p. 5.
[4] D. S. Edelman and C. F. Bellows, “Umbilical Herniorra-
phy Reinforced with Biologic Mesh,” The American
Surgery, Vol. 76, No. 11, 2010, pp. 1205-1209.
[5] A. Arroyo, P. García, F. Pérez, et al., “Randomized Clini-
cal Trial Comparing Suture and Mesh Repair of Umbili-
cal Hernia in Adults,” British Journal of Surgery, Vol. 88,
No. 10, 2001, pp. 1321-1323.
http://dx.doi.org/10.1046/j.0007-1323.2001.01893.x
[6] B. E. Wright, J. Beckerman, M. Cohen, et al., “Is Laparo-
scopic Umbilical Hernia Repair with Mesh a Reasonable
Alternative to Conventional Repair?” The American
Journal of Surgery, Vol. 184, No. 6, 2002, pp. 505-508.
http://dx.doi.org/10.1016/S0002-9610(02)01071-1
[7] W. S. Cobb, A. M. Carbonell, C. L. Kalbaugh, et al.,
“Infection Risk of Open Placement of Intraperitoneal
Composite Mesh,” The American Surgery, Vol. 75, No. 9,
2009, pp. 762-768.
[8] S. Petersen, G. Henke, M. Freitag, et al., “Deep Prosthesis
Infection in Incisional Hernia Repair: Predictive Factors
and Clinical Outcome,” European Journal of Surgery,
Vol. 167, No. 6, 2001, pp. 453-457.
http://dx.doi.org/10.1080/110241501750243815
[9] J. R. Eriksen, T. Gogenur and J. Rosenberg, “Choice of
Mesh for Laparoscopic Ventral Hernia Repair,” Hernia,
Vol. 11, No. 6, 2007, pp. 481-492.
http://dx.doi.org/10.1007/s10029-007-0282-8
[10] D. Foschi, F. Corsi, P. Cellerino, et al., “Late Rejection of
the Mesh after Laparoscopic Hernia Repair,” Surgical
Endoscopy, Vol. 12, No. 5, 1998, pp. 455-457.
http://dx.doi.org/10.1007/s004649900704
[11] W. S. Cobb, K. W. Kercher and B. T. Heniford, “Laparo-
scopic Repair of Incisional Hernias,” Surgical Clinics of
North America, Vol. 85, No. 1, 2005, pp. 91-103.
http://dx.doi.org/10.1016/j.suc.2004.09.006
[12] M. Korenkov, A. Paul, S. Sauerland, et al., “Classification
and Surgical Treatment of Incisional Hernia: Results of
an Experts’ Meeting,” Langenbeck’s Archives of Surgery,
Vol. 386, No. 1, 2001, pp. 65-73.
http://dx.doi.org/10.1007/s004230000182
[13] V. M. Sanchez, Y. E. Abi-Haidar and K. M. Itani, “Mesh
Infection in Ventral Incisional Hernia Repair: Incidence,
Contributing Factors, and Treatment,” Surgical Infections
(Larchmt), Vol. 12, No. 3, 2011, pp. 205-210.
http://dx.doi.org/10.1089/sur.2011.033
[14] M. N. Mavros, S. Athanasiou, V. G. Alexiou, et al., “Risk
Factors for Mesh-Related Infections After Hernia Repair
Surgery: A Meta-Analysis of Cohort Studies,” World
Journal of Surgery, Vol. 35, No. 11, 2011, pp. 2389-2398.
http://dx.doi.org/10.1007/s00268-011-1266-5
[15] A. Agrawal and R. Avill, “Mesh Migration Following
Repair of Inguinal Hernia: A Case Report and Review of
Literature,” Hernia, Vol. 10, No. 1, 2006, pp. 79-82.
http://dx.doi.org/10.1007/s10029-005-0024-8
[16] P. K. Chowbey, N. Bagchi, A. Goel, et al., ”Mesh Migra-
tion into the Bladder after TEP Repair: A Rare Case Re-
port,” Surgical Laparoscopy, Endoscopy & Percutaneous
Techniques, Vol. 16, No. 1, 2006, pp. 52-53.
Copyright © 2013 SciRes. SS